Pharmaids Pharmaceuticals share news, announcements and annual reports
BSE: 524572Pharmaceuticals & BiotechnologySmall Cap
Pharmaids Pharmaceuticals Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1994
Last close ₹27.72down ₹0.70 (2.46%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹28.42.
30 Oct: open ₹28.00, high ₹28.89, low ₹27.50
52-week range of traded prices to 30 Oct 2026
₹25.60Low, 1 Jun 2026₹53.90High, 9 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹98 Cr2,774th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.05
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −8.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹6.70 crore of one-off items, the largest of them in the quarter to Jun 2026.
- −21.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.44
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,285
Pharmaids Pharmaceuticals board meetings
125 filed, newest first. Page 2 of 3.
Jan 2023
Dec 2022
1 Dec · Board meeting
Meeting on 6 Dec 20221 Dec · Board meeting
Nov 2022
23 Nov · Board meeting
Meeting on 29 Nov 2022: preferential issue of shares2 Nov · Board meeting
Meeting on 9 Nov 2022: quarterly results
Oct 2022
13 Oct · Board meeting
7 Oct · Board meeting
Meeting on 13 Oct 2022: issue of warrants
Jul 2022
14 Jul · Board meeting
Meeting on 22 Jul 2022: quarterly results and annual general meeting
May 2022
12 May · Board meeting
Meeting on 21 May 2022: audited results
Jan 2022
20 Jan · Board meeting
Meeting on 28 Jan 2022: quarterly results
Oct 2021
29 Oct · Board meeting
Meeting on 9 Nov 2021: quarterly results
Aug 2021
13 Aug · Board meeting
Meeting on 20 Aug 2021: annual general meeting
Jul 2021
16 Jul · Board meeting
Meeting on 23 Jul 2021: quarterly results
May 2021
17 May · Board meeting
Meeting on 24 May 2021: quarterly results
Feb 2021
1 Feb · Board meeting
Meeting on 5 Feb 2021: quarterly results
Jan 2021
Nov 2020
20 Nov · Board meeting
Meeting on 20 Nov 2020
Oct 2020
19 Oct · Board meeting
Meeting on 12 Nov 2020: quarterly results
Aug 2020
6 Aug · Board meeting
Meeting on 13 Aug 2020: quarterly results
Jul 2020
May 2020
22 May · Board meeting
Meeting on 29 May 2020: audited results and quarterly results
Mar 2020
Jan 2020
10 Jan · Board meeting
Meeting on 13 Feb 2020: quarterly results
Oct 2019
17 Oct · Board meeting
Meeting on 13 Nov 2019: quarterly results5 Oct · Board meeting
Aug 2019
27 Aug · Board meeting